Triglyceride glucose index: a novel biomarker in the management of patients with psoriasis.

Objective: Triglyceride glucose index is a recently described biomarker that has been associated with various systemic disorders such as cardiovascular diseases. Within this study, we evaluated the effect of biological agent treatment on triglyceride glucose index in patients with psoriasis.

Patients And Methods: Between April 2019 and October 2022, the triglyceride glucose index was retrospectively reviewed in patients with psoriasis before and three months after the initiation of biological agent treatment.